167 related articles for article (PubMed ID: 35224708)
1. Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.
Kaur K; Shah A; Gandhi J; Trivedi P
J Egypt Natl Canc Inst; 2022 Feb; 34(1):9. PubMed ID: 35224708
[TBL] [Abstract][Full Text] [Related]
2. Mucinous cystadenocarcinoma of the breast with amplification of the HER2-gene confirmed by FISH: The first case reported.
Petersson F; Pang B; Thamboo TP; Putti TC
Hum Pathol; 2010 Jun; 41(6):910-3. PubMed ID: 20338619
[TBL] [Abstract][Full Text] [Related]
3. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
[TBL] [Abstract][Full Text] [Related]
4. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
5. Primary mucinous cystadenocarcinoma of the breast: a clinicopathologic analysis of one case and review of the literature.
Wang X; Li Y; Zhao P; Jia H; Dong X; Zhang L; Wang C
Int J Clin Exp Pathol; 2020; 13(10):2562-2568. PubMed ID: 33165376
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
[TBL] [Abstract][Full Text] [Related]
7. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
[TBL] [Abstract][Full Text] [Related]
8. Mature cystic teratoma with co-existent mucinous cystadenocarcinoma: describing a diagnostic challenge-a case report.
Chahkandi M; Mozayani F; Fanoodi A; Bina AR; Ebrahimian AR
J Med Case Rep; 2024 May; 18(1):232. PubMed ID: 38704586
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas.
Gagne LJ; Colacchio T; Longnecker DS
Int J Pancreatol; 2000 Aug; 28(1):9-13. PubMed ID: 11185714
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
Strickland S; Parra-Herran C
Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
[TBL] [Abstract][Full Text] [Related]
11. Primary mucinous cystadenocarcinoma of the breast with amplification of the HER2 gene confirmed by FISH - case report and review of the literature.
Kucukzeybek BB; Yigit S; Sari AA; Rezanko T; Durak E; Sadullahoglu C
Pol J Pathol; 2014 Mar; 65(1):70-3. PubMed ID: 25119013
[TBL] [Abstract][Full Text] [Related]
12. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
[TBL] [Abstract][Full Text] [Related]
13. Mucinous cystadenocarcinoma of the breast with a basal-like immunophenotype.
Deng Y; Xue D; Wang X; Xu S; Ao Q; Hu Z; Wang G
Pathol Int; 2012 Jun; 62(6):429-32. PubMed ID: 22612513
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma.
Bassiouny D; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Parra-Herran C; Chiu HF; Naeim M; Li N; Khalifa M; Nofech-Mozes S
Int J Surg Pathol; 2018 Jun; 26(4):306-317. PubMed ID: 29338553
[TBL] [Abstract][Full Text] [Related]
15. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
[TBL] [Abstract][Full Text] [Related]
16. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm.
Aldaoud N; Erashdi M; AlKhatib S; Abdo N; Al-Mohtaseb A; Graboski-Bauer A
BMC Res Notes; 2019 Nov; 12(1):770. PubMed ID: 31771640
[TBL] [Abstract][Full Text] [Related]
17. Co-Existing Ovarian Mucinous Cystadenocarcinoma with Mature Cystic Teratoma: A Rare Case Report.
Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Piyawong W; Himakhun W; Bhamarapravatana K
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S281-6. PubMed ID: 29927186
[TBL] [Abstract][Full Text] [Related]
18. Primary Mucinous Cystadenocarcinoma of the Breast: A Rare Case Report With Review of Literature.
Jain E; Kumar A; Jain R; Sharma S
Int J Surg Pathol; 2021 Oct; 29(7):740-746. PubMed ID: 33635116
[TBL] [Abstract][Full Text] [Related]
19. [Endometrioid adenocarcinoma of the uterine cervix associated with mucinous ovarian cystadenocarcinoma].
Ferchichi L; Rammeh-Rommani S; Ben Hammouda S; Sfar R; Farah F; Ben Jilani S; Zermani R
Gynecol Obstet Fertil; 2006 May; 34(5):410-2. PubMed ID: 16677843
[TBL] [Abstract][Full Text] [Related]
20. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
Schmoeckel E; Kirchner T; Mayr D
Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
